Recent News

• 04.24.2025 - Teleflex Announces Clinical and Real-World Evidence Studies and Physician Educational Opportunities to Be Highlighted at the 2025 American Urological Association (AUA) Annual Meeting
• 04.17.2025 - Teleflex Announces First Quarter 2025 Earnings Conference Call Information
• 04.01.2025 - Teleflex Receives FDA 510(k) Clearance of the AC3 Range™ Intra-Aortic Balloon Pump (IABP)
• 03.27.2025 - Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference
• 03.25.2025 - Teleflex Announces Updated Clinical Study Data Presented at the European Association of Urology (EAU) Congress

Recent Filings

• 04.03.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.28.2025 - ARS Annual Report to Security Holders
• 03.28.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 03.28.2025 - DEF 14A Other definitive proxy statements
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities